THERALINK TECHNOLOGIES, INC. Quarterly Debt-to-equity in % from Q2 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Theralink Technologies, Inc. quarterly Debt-to-equity history and growth rate from Q2 2012 to Q4 2023.
  • Theralink Technologies, Inc. Debt-to-equity for the quarter ending December 31, 2023 was -104 %, a 0.98% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 -104 -1.01 -0.98% Dec 31, 2023
Q3 2023 -106 -12.6 -13.5% Sep 30, 2023
Q2 2023 -105 -17.4 -19.9% Jun 30, 2023
Q1 2023 -104 -15.8 -17.9% Mar 31, 2023
Q4 2022 -103 -16.8 -19.4% Dec 31, 2022
Q3 2022 -93 -8 -9.42% Sep 30, 2022
Q2 2022 -87.2 +19.2 +18.1% Jun 30, 2022
Q1 2022 -88.4 +82.9 +48.4% Mar 31, 2022
Q4 2021 -86.6 -4.64K -102% Dec 31, 2021
Q3 2021 -85 -1.11K -108% Sep 30, 2021
Q2 2021 -106 -1.23K -109% Jun 30, 2021
Q1 2021 -171 -5K -104% Mar 31, 2021
Q4 2020 4.56K +6.93K Dec 31, 2020
Q3 2020 1.03K +1.82K Sep 30, 2020
Q2 2020 1.13K Jun 30, 2020
Q1 2020 4.83K Mar 31, 2020
Q4 2019 -2.37K Dec 31, 2019
Q3 2019 -788 Sep 30, 2019
Q2 2013 182 -300 -62.3% May 31, 2013
Q1 2013 201 Feb 28, 2013
Q4 2012 190 Nov 30, 2012
Q3 2012 268 Aug 31, 2012
Q2 2012 482 May 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.